BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1370 related articles for article (PubMed ID: 33947753)

  • 1. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of galectin-3: an increasingly promising target in COVID-19.
    Caniglia JL; Asuthkar S; Tsung AJ; Guda MR; Velpula KK
    F1000Res; 2020; 9():1078. PubMed ID: 33082935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 as the new player in staging and prognosis of COVID-19.
    Markovic SS; Gajovic N; Jurisevic M; Jovanovic M; Jovicic BP; Arsenijevic N; Mijailovic Z; Jovanovic M; Dolicanin Z; Jovanovic I
    Sci Rep; 2022 Jan; 12(1):1272. PubMed ID: 35075140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients.
    Cervantes-Alvarez E; la Rosa NL; la Mora MS; Valdez-Sandoval P; Palacios-Jimenez M; Rodriguez-Alvarez F; Vera-Maldonado BI; Aguirre-Aguilar E; Escobar-Valderrama JM; Alanis-Mendizabal J; Méndez-Guerrero O; Tejeda-Dominguez F; Torres-Ruíz J; Gómez-Martín D; Colborn KL; Kershenobich D; Huang CA; Navarro-Alvarez N
    Sci Rep; 2022 Feb; 12(1):1856. PubMed ID: 35115644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19.
    Wang YC; Tsai CH; Wang YC; Yen LC; Chang YW; Sun JR; Lin TY; Chiu CH; Chao YC; Chang FY
    Infection; 2024 Jun; 52(3):955-983. PubMed ID: 38133713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal-fetal interface.
    Zhao F; Tallarek AC; Wang Y; Xie Y; Diemert A; Lu-Culligan A; Vijayakumar P; Kittmann E; Urbschat C; Bayo J; Arck PC; Farhadian SF; Dveksler GS; Garcia MG; Blois SM
    Front Immunol; 2023; 14():1196395. PubMed ID: 37475853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.
    Elnosary ME; Shreadah MA; Ashour ML; Nabil-Adam A
    Int Immunopharmacol; 2024 Jan; 126():111072. PubMed ID: 38006751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
    Lodge S; Nitschke P; Kimhofer T; Coudert JD; Begum S; Bong SH; Richards T; Edgar D; Raby E; Spraul M; Schaefer H; Lindon JC; Loo RL; Holmes E; Nicholson JK
    J Proteome Res; 2021 Feb; 20(2):1382-1396. PubMed ID: 33426894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
    Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
    Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.
    Shahbaz S; Bozorgmehr N; Lu J; Osman M; Sligl W; Tyrrell DL; Elahi S
    Microbiol Spectr; 2023 Sep; 11(5):e0125623. PubMed ID: 37676005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.